KYNA is considered as a neuroprotective NMDA-R antagonist, while QUIN as a neurotoxic NMDA-R agonist. The imbalance between the neurotoxic and neuroprotective properties of kynurenines receives the most attention in patients with brain functional disorders
377 followers
377 followers
1,000 followers
RT @Metabbot: The Metabolic Factor Kynurenic Acid of Kynurenine Pathway Predicts Major Depressive Disorder. Front Psychiatry #metabolomics…
339 followers
RT @realBioMassSpec: The Metabolic Factor Kynurenic Acid of Kynurenine Pathway Predicts Major Depressive Disorder #FrontPsych #MassSpec htt…